Mobilization of Hematopoietic Progenitor Cells with Standard or Reduced Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients. a Randomized Prospective Single Center Phase II Study.
Samaras P et al. Biol Blood Marrow Transplant. 2017 Dec 12. pii: S1083-8791(17)31679-8. doi: 10.1016/j.bbmt.2017.12.775. [Epub ahead of print].

Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network.
Ludwig H et al.Leukemia. 2017 Dec 18. doi: 10.1038/leu.2017.353. [Epub ahead of print].

Bisphosphonates in multiple myeloma: an updated network meta-analysis.
Mhaskar R et al. Cochrane Database Syst Rev. 2017 Dec 18;12:CD003188. doi: 10.1002/14651858.CD003188.pub4. [Epub ahead of print].

Role of Plasmapheresis in the Management of Acute Kidney Injury in Patients With Multiple Myeloma: Should We Abandon It?
Premuzic V et al. Ther Apher Dial. 2017 Dec 14. doi: 10.1111/1744-9987.12606. [Epub ahead of print].

Antibacterial Prophylaxis with Ciprofloxacin for Patients with Multiple Myeloma and Lymphoma Undergoing Autologous Haematopoietic Cell transplantation: A Quasi-experimental Single Centre Before-after Study.
Yeshurun M et al. Clin Microbiol Infect. 2017 Dec 2. pii: S1198-743X(17)30650-X. doi: 10.1016/j.cmi.2017.11.019. [Epub ahead of print].

Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.
Bridoux F et al. JAMA. 2017 Dec 5;318(21):2099-2110. doi: 10.1001/jama.2017.17924.

High-Cutoff Hemodialysis in Myeloma Cast Nephropathy.
Jhaveri KD et al. JAMA. 2017 Dec 5;318(21):2085-2086. doi: 10.1001/jama.2017.18710.

Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia.
Vacca A et al. Clin Immunol. 2017 Nov 27. pii: S1521-6616(17)30633-2. doi: 10.1016/j.clim.2017.11.014. [Epub ahead of print].

Plasma exchange in the management of new onset multiple myeloma with cast nephropathy treated with bortezomib based chemotherapy.
Sethi J et al. Nephrology (Carlton). 2017 Dec;22(12):1035-1036. doi: 10.1111/nep.12979.